Status:
COMPLETED
Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal Donors
Lead Sponsor:
Amgen
Conditions:
Normal PBPC Donors
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to clinically evaluate the spleen during PBPC mobilization by filgrastim in normal donors.
Eligibility Criteria
Inclusion
- Eligible to be PBPC donor for allogeneic transplantation as determined by local institution
Exclusion
- History of splenectomy - Previous PBPC mobilization attempts - Previous treatment with GCSF or GMCSF
Key Trial Info
Start Date :
November 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2007
Estimated Enrollment :
309 Patients enrolled
Trial Details
Trial ID
NCT00115128
Start Date
November 1 2003
End Date
September 1 2007
Last Update
May 13 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.